Campbell & Co Investment Adviser’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,458
Closed -$420K 1024
2026
Q1
$420K Buy
+11,458
New +$452K 0.02% 797
2025
Q3
Sell
-19,447
Closed -$605K 1074
2025
Q2
$605K Buy
+19,447
New +$526K 0.04% 722
2024
Q4
Sell
-31,001
Closed -$825K 1043
2024
Q3
$825K Buy
31,001
+15,449
+99% +$402K 0.06% 508
2024
Q2
$399K Buy
+15,552
New +$349K 0.03% 736
2018
Q4
Sell
-8,860
Closed -$312K 326
2018
Q3
$312K Buy
+8,860
New +$286K 0.21% 201
2017
Q4
Sell
-15,587
Closed -$354K 387
2017
Q3
$354K Buy
+15,587
New +$314K 0.29% 123
2017
Q1
Sell
-11,617
Closed -$222K 145
2016
Q4
$222K Buy
+11,617
New +$212K 0.69% 75

Other funds holding AORT

Campbell & Co Investment Adviser's AORT Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Artivion (AORT) in Q2 2026, closing a stake of 11,458 shares — an estimated $420K sold.

Campbell & Co Investment Adviser first reported a position in AORT in Q4 2016 and held it in 7 quarters. The position peaked at $825K in Q3 2024. 73 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 11,458 Artivion shares in Q2 2026, an estimated $420K.
  • Campbell & Co Investment Adviser first reported a position in Artivion in Q4 2016 and held it in 7 quarters.
  • Campbell & Co Investment Adviser's Artivion position peaked at $825K in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.